Liothyronine Sodium
NDC 50090-3131, Liothyronine Sodium, tablet, from A-S Medication Solutions.
- Product NDC
- 50090-3131
- Status
- Listed
- Labeler
- A-S Medication Solutions
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200295
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50090-3131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM5 ug/1
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50090-3131-0 | 50090313100 | 100 TABLET in 1 BOTTLE (50090-3131-0) |
| 50090-3131-1 | 50090313101 | 90 TABLET in 1 BOTTLE (50090-3131-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/db65bcd8-e9c9-4095-9975-03be1f443823
Use it
Look up 50090-3131 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50090-3131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50090-3131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.